Sildenafil Tablet, Film Coated
Product Images NDC 51655-468

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 51655-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 468 54)

Sildenafil Tablets USP 100 mg label for a 15-tablet package by Northwind Health Company, LLC. The label includes dosage form as film-coated tablets for oral use, storage instructions, and identifies the product as prescription only with NDC 51655-468-54.*

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

Bar chart illustrating the percentage of patients reporting improvement across different treatment groups, including Placebo and Sildenafil Citrate Tablets at 25 mg, 50 mg, and 100 mg doses. The vertical axis represents the percentage of patients reporting improvement, while the horizontal axis lists the treatment groups with corresponding sample sizes.*

FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

A line graph showing the effect of Sildenafil 100 mg versus placebo on systolic blood pressure over 24 hours. The x-axis represents time post dose in hours, from pre-dose to 24 hours, and the y-axis shows changes in systolic blood pressure in mmHg. Two lines plot the blood pressure changes for Sildenafil 100 mg and placebo groups respectively.*

FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

A line graph comparing changes in a variable labeled as 'Change in HR (BPM)' over time in hours on the x-axis. Two data series are shown: one for 'Domacein & Placebo' indicated by blue squares and another for 'Domacein & Cialis 100 mg' indicated by black crosses, demonstrating variations in heart rate changes over an 8-hour period.*

FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

A line graph comparing two treatments over time, showing change in a measured variable as a percentage on the y-axis against time postdose in hours on the x-axis. The graph includes two lines: one in blue representing Doxazosin plus placebo and another in gray for Doxazosin plus Sildenafil 50 mg.*

FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

A line chart showing blood pressure (mmHg) over time (hours) after dosing for two treatments: Doxazosin with Sildenafil 100 mg and Doxazosin with Placebo. The chart compares the changes in blood pressure for the two groups over an 8-hour period post-dosing.*

FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

A line graph depicting plasma concentration (ng/mL) over time (hours) following a dose of a commercial tablet. The x-axis represents time post-dose from 0 to 24 hours, and the y-axis indicates plasma concentration levels from 0 to 500 ng/mL, showing the pharmacokinetic profile of the drug.*

FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

A bar chart displaying the percentage of patients at endpoint on the vertical axis against baseline scores on the horizontal axis ranging from 0 to 5. The chart uses six different shaded bars labeled from 0 to 5 to represent categories or groups within each baseline score.*

FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

Bar chart depicting the percentage of patients at endpoint across different baseline scores, with multiple data series represented by varying shades of bars labeled 00 through 05. The x-axis shows baseline scores from 0 to 5, and the y-axis shows the percentage of patients at endpoint, ranging from 0 to 80 percent.*

FDA Label Image

Sildenafilheterologo1 (Sildenafilheterologo1)

FDA Label Image

Sildenafilheterologo2 (Sildenafilheterologo2)

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Chemical structure of Sildenafil, showing its molecular components including the pyrazolo-pyrimidinone core, sulfonamide group, and associated functional groups as part of its active ingredient representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.